• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ASRT

ASRT

Assertio Holdings, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD23.47

+0.02 (+0.09%)

Rating:C+

Company Profile

CEO

Mark L. Reisenauer

IPO Date

1997-12-03

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$23.44

Prev. Close

$23.45

Day Low

$23.44

Day High

$23.47

52W Low

$8.61

52W High

$23.47

Market Cap

$0.15B

Volume

0.13M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

16.4%

Avg Negative

12.2%

Avg Neutral

71.4%

News Feed

Assertio Holdings, Inc. (ASRT) CEO Dan Peisert on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/5/2021·↓ negative

Assertio (ASRT) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research·8/5/2021·↑ positive

Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewsWire·6/4/2021·↑ positive

Assertio Holdings, Inc. Announces 1-for-4 Reverse Stock Split

GlobeNewsWire·5/17/2021·↑ positive

Assertio Holdings, Inc. Announces Adjournment of Annual Meeting of Shareholders

GlobeNewsWire·5/17/2021·↑ positive

ASRT Stock: Over 30% Increase Pre-Market Explanation

Pulse2·5/7/2021·↑ positive

Assertio Holdings' (ASRT) CEO Dan Peisert on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/6/2021·↓ negative

Assertio Holdings, Inc. to Report First Quarter 2021 Financial Results After the Close of Markets on Thursday, May 6, 2021

GlobeNewsWire·4/22/2021·↓ negative

Assertio Holdings: Bankruptcy, Sale Or Success - How Management Can Rapidly Deliver Triple-Digit Upside

Seeking Alpha·3/16/2021·↓ negative

Implied Volatility Surging for Assertio Holdings (ASRT) Stock Options

Zacks Investment Research·3/15/2021·↓ negative